Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Cash Flows From Operating Activities:
Net loss	$ (25,095,075)	$ (19,069,836)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense	2,518,001	81,410
Accretion of financing costs	1,904,546	1,865,154
Amortization of right-of-use asset	52,315	50,525
Write-down of inventory to net realizable value	2,394,274
Unrealized loss on investment		5,497
Stock-based compensation	9,502,030	7,691,511
Shares issued for professional services		(448)
Change in fair value of derivative liability	(705,184)	229,473
Change in fair value of conversion option	(138,060)
Change in fair value of liability-classified equity-linked contracts	(737,040)
Loss on extinguishment of debt	675,648
Loss on private placement	567,161
Changes in operating assets and liabilities:
Accounts receivable	(95,476)
Inventory	(2,814,057)	(489,238)
Grants receivable	164,403	(326,170)
Prepaid expenses and deposits	1,285,820	416,234
Other current assets		(316,351)
Accounts payable and accrued liabilities	(2,053,400)	2,502,865
Right-of-use lease liabilities	(241,884)	(59,326)
Net Cash Used in Operating Activities	(12,815,978)	(7,418,700)
Cash Flows From Investing Activities:
Other acquisition deposits		(279,878)
Acquisition of property, plant and equipment, and water rights	(1,509,581)	(10,418,868)
Purchase of water rights/intangible assets		(169,714)
Net Cash Used in Investing Activities	(1,509,581)	(10,868,460)
Cash Flows From Financing Activities:
Proceeds from exercise of share purchase warrants		37,499
Proceeds from employee stock purchase plan	140,746
Proceeds from issuance of common shares through At-The-Market offering	7,579,122
Proceeds from subscription agreements (Note 13)	1,900,000
Proceeds from registered direct offerings	15,000,000
Payment of issuance costs, registered direct offerings	(1,089,000)
Proceeds from notes payable, net of issuance costs	9,900,000	20,287,118
Principal paid on notes payable	(5,483,333)	(11,400,000)
Proceeds from share purchase agreement, net of issuance costs		14,689,178
Net Cash Provided by Financing Activities	27,947,535	23,613,795
Increase in Cash and Restricted Cash	13,621,976	5,326,635
Cash and Restricted Cash – Beginning of Period	7,001,786	2,320,149
Cash and Restricted Cash – End of Period	$ 20,623,762	$ 7,646,784